Tenet Healthcare Corporation (NYSE:THC – Get Free Report) rose 11.8% during trading on Wednesday following a stronger than expected earnings report. The stock traded as high as $216.04 and last traded at $215.90. Approximately 897,753 shares changed hands during trading, a decline of 4% from the average daily volume of 933,138 shares. The stock had previously closed at $193.04.
The company reported $4.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.08 by $0.62. The company had revenue of $5.53 billion for the quarter, compared to analysts’ expectations of $5.47 billion. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The firm’s quarterly revenue was up 8.9% on a year-over-year basis. During the same quarter last year, the company posted $3.44 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS.
Trending Headlines about Tenet Healthcare
Here are the key news stories impacting Tenet Healthcare this week:
- Positive Sentiment: Q4 beat and strong results: Tenet reported $4.70 EPS vs. $4.08 est. and $5.53B revenue (up ~8.9% YoY); management highlighted revenue and EBITDA growth that underpins the market rally. Tenet Reports Strong Fourth Quarter and FY 2025 Results; Provides 2026 Financial Outlook
- Positive Sentiment: Raised 2026 outlook: Tenet issued EPS guidance of $16.19–$18.47 and an adjusted EBITDA target of $4.485B–$4.785B, signaling confidence in cash flow and M&A optionality. Tenet Healthcare outlines $4.485B–$4.785B 2026 adjusted EBITDA target amid structural cost initiatives and M&A focus
- Positive Sentiment: Analyst upgrade/price-target lift: Jefferies raised its price target to $265 and keeps a Buy rating, providing additional analyst support for further upside. Jefferies Raises Price Target to $265 (Benzinga)
- Positive Sentiment: Market reaction: Shares hit a new one‑year/all‑time high on the beat and outlook, indicating strong investor appetite after the results. Tenet Healthcare (NYSE:THC) Hits New 1-Year High on Better-Than-Expected Earnings
- Neutral Sentiment: Full earnings materials and call transcripts are available for deeper review (slides and transcript show drivers behind the guide and cost initiatives). Tenet Healthcare Corporation 2025 Q4 – Results – Earnings Call Presentation
- Negative Sentiment: Policy headwind: Tenet expects about a $250M hit this year from the loss of ACA subsidies, a near‑term earnings and cash‑flow headwind investors must account for. Tenet expects $250M hit from loss of ACA subsidies this year
- Negative Sentiment: Margin risk for 2026: Some analysts note the guidance midpoint implies potential pressure on 2026 EBITDA margins even as revenue guidance was lifted — monitor margin execution and cost initiatives closely. Tenet Healthcare Beats Q4 Earnings: But 2026 EBITDA Margin May Decline
Analysts Set New Price Targets
Read Our Latest Stock Report on THC
Insider Transactions at Tenet Healthcare
In related news, Director Nadja West sold 2,178 shares of the business’s stock in a transaction that occurred on Monday, December 15th. The stock was sold at an average price of $197.47, for a total value of $430,089.66. Following the transaction, the director directly owned 28,480 shares of the company’s stock, valued at approximately $5,623,945.60. The trade was a 7.10% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.81% of the company’s stock.
Institutional Trading of Tenet Healthcare
Hedge funds have recently modified their holdings of the company. Triumph Capital Management bought a new stake in Tenet Healthcare in the third quarter worth $25,000. Activest Wealth Management bought a new stake in shares of Tenet Healthcare in the 4th quarter worth about $26,000. Elyxium Wealth LLC bought a new position in shares of Tenet Healthcare in the 4th quarter valued at about $29,000. William B. Walkup & Associates Inc. purchased a new position in Tenet Healthcare in the third quarter worth about $32,000. Finally, Canada Pension Plan Investment Board purchased a new stake in Tenet Healthcare during the second quarter valued at approximately $35,000. 95.44% of the stock is owned by hedge funds and other institutional investors.
Tenet Healthcare Price Performance
The firm has a market capitalization of $20.44 billion, a P/E ratio of 15.01, a price-to-earnings-growth ratio of 0.95 and a beta of 1.44. The company has a current ratio of 1.76, a quick ratio of 1.64 and a debt-to-equity ratio of 2.18. The firm has a 50 day moving average price of $198.41 and a 200-day moving average price of $194.17.
About Tenet Healthcare
Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.
In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.
Read More
- Five stocks we like better than Tenet Healthcare
- Nvidia CEO Issues Bold Tesla Call
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- The day the gold market broke
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
